Dear Colleagues,
This question is directed to those of you who are administrators for NCI
supported cancer center cores. When determining pricing, does your
institution support a two price model (cancer center vs. non-cancer center
members) differentiated by financial support provided by CCSG vs.
institution/other
OR
one subsidized pricing model that represents an aggregate of financial support
(CCSG plus institution and other support)?
If you would rather respond to me directly, my contact information is listed
below.
Thank you in advance,
Sheenah
Sheenah Mische, Ph.D.
Sr. Director, Advanced Research Technologies
Associate Professor, Department of Pathology
NYU Langone Health
540 First Avenue
New York, NY 10021
T: 212 263 0859
M: 347 407 2768
<email obscured><email obscured>>
NYU_DART<https://med.nyu.edu/research/scientific-cores-shared-resources/division-advanced-research-technologies>
Rest of post
------------------------------------------------------------
This email message, including any attachments, is for the sole use of the
intended recipient(s) and may contain information that is proprietary,
confidential, and exempt from disclosure under applicable law. Any unauthorized
review, use, disclosure, or distribution is prohibited. If you have received
this email in error please notify the sender by return email and delete the
original message. Please note, the recipient should check this email and any
attachments for the presence of viruses. The organization accepts no liability
for any damage caused by any virus transmitted by this email.
=================================
Hi
UIC gives reduced rate based on CC support.
Sent from my iPhone
> On Jul 26, 2018, at 4:48 PM, Mische, Sheenah <email obscured>>
wrote:
>
> Dear Colleagues,
>
> This question is directed to those of you who are administrators for NCI
supported cancer center cores. When determining pricing, does your
institution support a two price model (cancer center vs. non-cancer center
members) differentiated by financial support provided by CCSG vs.
institution/other
> OR
> one subsidized pricing model that represents an aggregate of financial
support (CCSG plus institution and other support)?
>
> If you would rather respond to me directly, my contact information is listed
below.
Rest of post
>
> Thank you in advance,
> Sheenah
>
> Sheenah Mische, Ph.D.
> Sr. Director, Advanced Research Technologies
> Associate Professor, Department of Pathology
> NYU Langone Health
> 540 First Avenue
> New York, NY 10021
> T: 212 263 0859
> M: 347 407 2768
> <email obscured><email obscured>>
>
NYU_DART<https://med.nyu.edu/research/scientific-cores-shared-resources/division-advanced-research-technologies>
>
>
> ------------------------------------------------------------
> This email message, including any attachments, is for the sole use of the
intended recipient(s) and may contain information that is proprietary,
confidential, and exempt from disclosure under applicable law. Any unauthorized
review, use, disclosure, or distribution is prohibited. If you have received
this email in error please notify the sender by return email and delete the
original message. Please note, the recipient should check this email and any
attachments for the presence of viruses. The organization accepts no liability
for any damage caused by any virus transmitted by this email.
> =================================
>
> ――
> View topic http://list.abrf.org/r/topic/d7PmC6CtQOHVG0h4VwKx1
> Leave group <email obscured>?Subject=Unsubscribe
>
Sheenah,
We have one internal rate that everyone (JHU) is charged and for our Cancer
Center members we apply a subsidy to that rate which reduces the final cost to
them. Essentially they are paying the same internal rate as everyone, it's
just that some of the payment for those charges are from a different funding
source (CCSG support). This is in keeping compliant with federal guidelines
which states that rates should not discriminate between activities Federal
awards, non-federal awards and internal funding sources.
Jeff
Jeffrey A. Smith, M.A.
SKCCC Shared Resources & Research Services
SOM Office for Faculty Research Resources
Johns Hopkins School of Medicine
Bunting-Blaustein Bldg / 5M43
1650 Orleans Street
Baltimore, MD 21287
Office 410 614-2299
Fax 410 614-9884
<email obscured>
Rest of post
-----Original Message-----
From: Core Administrators Network Forum <email obscured>> On Behalf Of
Mische, Sheenah
Sent: Thursday, July 26, 2018 4:48 PM
To: CAN-CC <email obscured>) <email obscured>>
Subject: [core administrators network forum] Cancer Center member pricing
Dear Colleagues,
This question is directed to those of you who are administrators for NCI
supported cancer center cores. When determining pricing, does your
institution support a two price model (cancer center vs. non-cancer center
members) differentiated by financial support provided by CCSG vs.
institution/other
OR
one subsidized pricing model that represents an aggregate of financial support
(CCSG plus institution and other support)?
If you would rather respond to me directly, my contact information is listed
below.
Thank you in advance,
Sheenah
Sheenah Mische, Ph.D.
Sr. Director, Advanced Research Technologies Associate Professor, Department of
Pathology NYU Langone Health
540 First Avenue
New York, NY 10021
T: 212 263 0859
M: 347 407 2768
<email obscured><email obscured>>
NYU_DART<https://med.nyu.edu/research/scientific-cores-shared-resources/division-advanced-research-technologies>
------------------------------------------------------------
This email message, including any attachments, is for the sole use of the
intended recipient(s) and may contain information that is proprietary,
confidential, and exempt from disclosure under applicable law. Any unauthorized
review, use, disclosure, or distribution is prohibited. If you have received
this email in error please notify the sender by return email and delete the
original message. Please note, the recipient should check this email and any
attachments for the presence of viruses. The organization accepts no liability
for any damage caused by any virus transmitted by this email.
=================================
――
View topic http://list.abrf.org/r/topic/d7PmC6CtQOHVG0h4VwKx1
Leave group <email obscured>?Subject=Unsubscribe
Greetings!
The UNMC CC Director believes that CCSG subsidies should help defray costs for
all. So we have a single subsidized pricing model that represents an aggregate
of financial support (CCSG plus institution and other support).
Paula
Rest of post
-----Original Message-----
From: Core Administrators Network Forum <email obscured>> On Behalf Of
Mische, Sheenah
Sent: Thursday, July 26, 2018 3:48 PM
To: CAN-CC <email obscured>) <email obscured>>
Subject: [core administrators network forum] Cancer Center member pricing
Dear Colleagues,
This question is directed to those of you who are administrators for NCI
supported cancer center cores. When determining pricing, does your
institution support a two price model (cancer center vs. non-cancer center
members) differentiated by financial support provided by CCSG vs.
institution/other
OR
one subsidized pricing model that represents an aggregate of financial support
(CCSG plus institution and other support)?
If you would rather respond to me directly, my contact information is listed
below.
Thank you in advance,
Sheenah
Sheenah Mische, Ph.D.
Sr. Director, Advanced Research Technologies Associate Professor, Department of
Pathology NYU Langone Health
540 First Avenue
New York, NY 10021
T: 212 263 0859
M: 347 407 2768
<email obscured><email obscured>>
NYU_DART<https://med.nyu.edu/research/scientific-cores-shared-resources/division-advanced-research-technologies>
------------------------------------------------------------
This email message, including any attachments, is for the sole use of the
intended recipient(s) and may contain information that is proprietary,
confidential, and exempt from disclosure under applicable law. Any unauthorized
review, use, disclosure, or distribution is prohibited. If you have received
this email in error please notify the sender by return email and delete the
original message. Please note, the recipient should check this email and any
attachments for the presence of viruses. The organization accepts no liability
for any damage caused by any virus transmitted by this email.
=================================
――
View topic http://list.abrf.org/r/topic/d7PmC6CtQOHVG0h4VwKx1
Leave group <email obscured>?Subject=Unsubscribe
The information in this e-mail may be privileged and confidential, intended
only for the use of the addressee(s) above. Any unauthorized use or disclosure
of this information is prohibited. If you have received this e-mail by mistake,
please delete it and immediately contact the sender.
Interesting. Our CC uses reduced pricing for core services as the major
inducement to get faculty to join the CC.
William Hendrickson
> On Jul 27, 2018, at 1:46 PM, Turpen, Paula B <email obscured>> wrote:
>
> Greetings!
> The UNMC CC Director believes that CCSG subsidies should help defray costs
for all. So we have a single subsidized pricing model that represents an
aggregate of financial support (CCSG plus institution and other support).
> Paula
>
> -----Original Message-----
> From: Core Administrators Network Forum <email obscured>> On Behalf Of
Mische, Sheenah
> Sent: Thursday, July 26, 2018 3:48 PM
> To: CAN-CC <email obscured>) <email obscured>>
> Subject: [core administrators network forum] Cancer Center member pricing
>
>
> Dear Colleagues,
>
> This question is directed to those of you who are administrators for NCI
supported cancer center cores. When determining pricing, does your
institution support a two price model (cancer center vs. non-cancer center
members) differentiated by financial support provided by CCSG vs.
institution/other
> OR
> one subsidized pricing model that represents an aggregate of financial
support (CCSG plus institution and other support)?
>
> If you would rather respond to me directly, my contact information is listed
below.
>
> Thank you in advance,
> Sheenah
>
> Sheenah Mische, Ph.D.
> Sr. Director, Advanced Research Technologies Associate Professor, Department
of Pathology NYU Langone Health
> 540 First Avenue
> New York, NY 10021
> T: 212 263 0859
> M: 347 407 2768
> <email obscured><email obscured>>
>
NYU_DART<https://med.nyu.edu/research/scientific-cores-shared-resources/division-advanced-research-technologies>
>
>
> ------------------------------------------------------------
> This email message, including any attachments, is for the sole use of the
intended recipient(s) and may contain information that is proprietary,
confidential, and exempt from disclosure under applicable law. Any unauthorized
review, use, disclosure, or distribution is prohibited. If you have received
this email in error please notify the sender by return email and delete the
original message. Please note, the recipient should check this email and any
attachments for the presence of viruses. The organization accepts no liability
for any damage caused by any virus transmitted by this email.
> =================================
>
> ――
> View topic http://list.abrf.org/r/topic/d7PmC6CtQOHVG0h4VwKx1
> Leave group <email obscured>?Subject=Unsubscribe
>
>
> The information in this e-mail may be privileged and confidential, intended
only for the use of the addressee(s) above. Any unauthorized use or disclosure
of this information is prohibited. If you have received this e-mail by mistake,
please delete it and immediately contact the sender.
Rest of post
>
> ――
> View topic http://list.abrf.org/r/topic/1CjmLrj5oe0LrGeExnxCiN
> Leave group <email obscured>?Subject=Unsubscribe
>